# Grok-4.1-Fast Review

**Role:** External referee review
**Model:** x-ai/grok-4.1-fast
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T15:25:22.186935
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 16783 in / 2804 out
**Response SHA256:** 812d6700795e736b

---

## 1. IDENTIFICATION AND EMPIRICAL DESIGN (CRITICAL)

The identification relies on a continuous-treatment DiD (Eq. \ref{eq:main}: $\log(\text{SCI}_f^{UK}) \times \text{Post}_t$, with département and quarter-year FEs), exploiting within-France cross-sectional variation in pre-determined UK social connectedness (Facebook SCI, GADM2 vintage, Oct 2021) to identify Brexit spillovers on log median housing prices/m² (DVF data, 2014Q1–2023Q4, 93 depts × 40 quarters = 3,523 obs.). Treatment timing is coherent: Post_t = 1 from 2016Q3 (first full post-referendum quarter, vote June 23, 2016); event study (Fig. 2, Eq. \ref{eq:event_study}) shows effects emerging immediately, consistent with sudden sterling shock/uncertainty. No post-treatment gaps; sample covers through 2023Q4, with COVID overlap addressed via 2014–2018 subsample (Table 6, Col 2: β=0.024, p=0.009).

**Key assumptions explicit but not fully credible:**

- **Parallel trends**: Event study pre-coefficients mostly flat/insignificant, but joint Wald test rejects (F=1.97, p=0.038 for 9 pre-periods; driven by τ=-4 outlier, β=-0.028, p=0.005; excluding it: p=0.093; Sec. A.2). Linear pre-trend test insignificant (β=0.005, p=0.15 pre-2016Q2), but marginal rejection undermines clean DiD. Dept-specific linear trends (Table 6, Col 5) attenuate UK effect to β=0.015 (p=0.217), while strengthening German placebo (β=0.064, p=0.001)—suggesting violation.

- **Exclusion**: Major threat: SCI_UK correlates with baseline characteristics (r=0.42 with SCI_DE; expensive/coastal/urban depts; Table 3 baseline price control kills β=0.003, p=0.70). German placebo (no Brexit shock) significant/larger (Table 1 Col 4: β=0.045, p=0.008; Table 6 Col 6: persists/strengthens). Swiss placebo validates method (Table 1 Col 6: β=0.015, p=0.05 for 2015 CHF shock), but fails to falsify exclusion for UK. Residualized SCI_UK (orthogonal to SCI_DE/CH) insignificant (Table 2 Cols 3–4: β=0.016, p=0.21). Exchange rate (GBP/EUR weakness) confirms timing but German also significant (Table 4 Col 4: β=-0.294, p=0.004). Threats discussed candidly (Secs. 5.2–5.4, 7.2), but not resolved—UK SCI proxies general "cosmopolitanism" diverging post-2016.

Overall, design coherent but not credible for causal claim of *UK-specific* Brexit spillovers (demand reallocation via networks). Captures composite (UK + European trends); mechanism heterogeneity (houses β=0.035 p=0.011 vs. apts null; Channel-facing β=0.122 p<0.001 vs. expat negative; Table 7–8) suggestive but not disentangling.

## 2. INFERENCE AND STATISTICAL VALIDITY (CRITICAL)

Valid and transparent—paper passes inference threshold.

- SE clustered by département (93 clusters; baseline SE=0.0114); two-way clustered (SE=0.0113, Table 9 Col 2); HC-robust (SE=0.0047, p<0.001, Col 3). Permutation (2,000 draws, reshuffle SCI across depts; Fig. 3, p=0.038; Table A.4). p-values/CIs appropriate; no permutation for placebos (but not needed).

- N=3,523 consistent across specs (unbalanced panel noted); binscatter (Fig. A.1) visualizes raw relation.

- Not staggered DiD (uniform Post_t), so no TWFE bias. No RDD. Bandwidth N/A.

- Event study CIs (Fig. 2) and diagnostics (Herfindahl=0.007, ~140 effective UK regions/dept; leave-one-out Fig. 4, Table 5) rule out concentration bias (Borusyak et al. 2022 standards met).

## 3. ROBUSTNESS AND ALTERNATIVE EXPLANATIONS

Extensive, but core threats persist.

- **Placebos/falsification**: German significant (multiple tables); Swiss positive placebo works; COVID subsample strengthens UK/German equally (Table 6).

- **Specs**: Baseline price/coastal/trans density controls kill effect (Table 3); dept trends attenuate (Table 6); residualization insignificant (Table 2); exchange rate absorbs Post but confounded (Table 4); prob vs. pop-weighted SCI identical (Fig. 6, Table 9).

- **Mechanisms**: Distinguished (Sec. 7: reduced-form vs. house/apt, geographic); house-specific rules out institutional flows; Channel/expat patterns suggest reallocation (credible qualitatively, but small subsamples: Channel N=342, Table 8).

- **Limitations**: Explicit (Sec. 7.2: SCI post-treatment? Pre-trends; buyer nationality data needed); external validity bounded (France-only, housing-only).

German placebo + price controls indicate omitted variables (cosmopolitan divergence) as primary alternative explanation; not fully addressed.

## 4. CONTRIBUTION AND LITERATURE POSITIONING

Clear niche: First SCI application to Brexit cross-border spillovers (positive demand reallocation to French housing); extends Bailey et al. (2018,2021), Burchardi et al. (2013) to national-border shocks; adds to Brexit lit (Sampson 2017, Born et al. 2019, Hassan 2024: mostly UK costs/global contagion, not positive neighbor spillovers). Housing angle novel (vs. trade/migration).

Sufficient coverage (method: Rauch 2001, Chaney 2014; policy: Bloom et al. 2025). No major omissions, but add Dube & Zilis (2019) or Adão et al. (2019) on shift-share ID diagnostics (beyond Goldsmith-Pinkham 2020 noted implicitly); Borusyak et al. (2022) for continuous-treatment DiD extensions.

## 5. RESULTS INTERPRETATION AND CLAIM CALIBRATION

Mostly well-calibrated/honest: Abstract/intro note "appreciation" (β=0.025, modest 0.7% per SD SCI) but qualify with German/price/trends; conclusions stress "composite" effect, redistribution > aggregate. Magnitude plausible (vs. 0.3–0.6% French GDP hit, Sec. 7.4). Heterogeneity supports mechanisms without overclaim.

Flags: Intro "social networks transmitted demand reallocation" (p1) slightly overstates (given confounders); expat "declines" (Table 8 β=-0.105 p=0.003) intriguing but N=493 small, noisy. No text-table contradictions (e.g., Table 1 matches text). Policy proportional (redistribution lesson, no bold claims).

## 6. ACTIONABLE REVISION REQUESTS

### 1. Must-fix issues before acceptance
- **Issue**: Parallel trends marginally rejected (p=0.038 joint pre); dept trends + price controls kill/attenuate UK effect (Tables 3,6). German placebo consistently larger/significant. **Why**: Undermines causal ID for UK-Brexit claim; top journals require clean exclusion/parallel trends. **Fix**: (i) Report event study *with dept trends* (stacked/high-dim AKM or Callaway-Sant'Anna interactors); (ii) Main spec residualizes SCI_UK on {SCI_DE, SCI_CH, baseline price, coastal} throughout (promote Table 2 Col 5 to baseline); (iii) Joint UK/DE/CH horse-race in all main tables (e.g., Table 1 Col 3 marginal).
- **Issue**: SCI timing (2021 vintage, post-Brexit). **Why**: Possible endogenous network formation. **Fix**: Cite/discuss pre-2016 vintages (Bailey 2018 US-county) or historical migration (e.g., instrument SCI with 2001–2011 Census UK expats in France).

### 2. High-value improvements
- **Issue**: Mechanism tables (7–8) on subsamples (Channel N=342; expat N=493); imprecise ext. validity. **Why**: Strengthens but noisy; journal expects power calcs or matching weights. **Fix**: Reweight subsamples to national (entropics via Goldsmith-Pinkham) or triple-diff (e.g., SCI_UK × Post × {house indicator, Channel indicator}); add buyer nationality from notarial data if available (noted Sec. 7.2).
- **Issue**: No aggregate demand check (e.g., INSEE unemployment unavailable). **Why**: Housing supply-inelastic; rules out macro channel. **Fix**: Proxy via transaction volume (Table 1 Col 5 null) + national aggregates; cite DVF limitations explicitly.

### 3. Optional polish
- Add Dube-Zilis (2019)/Adão et al. (2019) citations for SCI concentration diagnostics.
- Power curves for event study pre-test sensitivity.

## 7. OVERALL ASSESSMENT

**Key strengths**: Novel question (positive Brexit spillovers via networks); rich data (DVF universe, SCI GADM2); exhaustive robustness (placebos, residualization, exchange rate); candid limitations; strong mechanisms (house/Channel/expat); valid inference.

**Critical weaknesses**: ID not credible—German placebo + price/trends reveal SCI_UK confounding by cosmopolitan divergence; marginal pre-trends; composite effect can't cleanly isolate UK-Brexit. Salvageable with residualization/trends as main spec.

**Publishability after revision**: Strong candidate for AEJ:Applied/Economic Policy post-minor revision; top-5 needs ID fixes for conditional accept.

**DECISION: MAJOR REVISION**